Roopa Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 796559,
    "name": "Roopa Industries",
    "stock_name": "Roopa Industries",
    "full_name": "Roopa Industries Ltd",
    "name_url": "stocks-analysis/roopa-industries",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "48.00",
    "chg": 3,
    "chgp": "6.67%",
    "dir": 1,
    "prev_price": "45.00",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530991,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE443C01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.22 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/roopa-industries-796559-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Roopa Industries Stock Falls to 52-Week Low of Rs.42 Amid Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-stock-hits-52-week-low-amidst-continued-underperformance-3746776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RoopaIndustries_priceRelatedfactors_3746776.png",
        "date": "2025-12-04 12:46:17",
        "description": "Roopa Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.42, reflecting a significant decline amid a day marked by high volatility and underperformance relative to its sector peers."
      },
      {
        "title": "Roopa Industries Stock Falls to 52-Week Low of Rs.43 Amidst Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-stock-falls-to-52-week-low-of-rs43-amidst-weak-fundamentals-3728655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoopaIndustries_priceRelatedfactors_3728655.png",
        "date": "2025-11-25 10:46:24",
        "description": "Roopa Industries, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.43 today, marking a significant price level amid a day of high volatility and mixed intraday movements."
      },
      {
        "title": "Roopa Industries Faces Financial Struggles Amid Declining Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-financial-trend-declines-from-positive-to-negative-amid-significant-performance-drop-3711587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoopaIndustries_fintrenddot_3711587.png",
        "date": "2025-11-18 11:02:05",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, reported a challenging financial quarter ending September 2025, with declines in key metrics such as operating cash flow and return on capital employed. Despite significant long-term growth, recent performance issues underscore the need for operational improvements."
      },
      {
        "title": "How has been the historical performance of Roopa Industries?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-roopa-industries-3703336",
        "imagepath": "",
        "date": "2025-11-14 23:55:45",
        "description": "Answer:\nThe historical performance of Roopa Industries shows significant growth in net sales and profit over the years.\n\nBreakdown:\nRoopa Industries has demonstrated a strong upward trend in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with a notable jump from 70.43 Cr in Mar'24. The total operating income followed a similar trajectory, reaching 120.69 Cr in Mar'25, up from 70.43 Cr in the previous year. However, raw material costs surged to 114.42 Cr in Mar'25, reflecting a substantial increase from 47.06 Cr in Mar'24. Despite this, the operating profit (PBDIT) rose to 6.41 Cr in Mar'25, compared to 5.68 Cr in Mar'24, indicating improved operational efficiency. Profit before tax also increased to 2.72 Cr in Mar'25 from 2.17 Cr in Mar'24, leading to a profit after tax of 2.03 Cr in Mar'25, up from 1.52 Cr in the prior year. The company's total assets grew to 76.46 Cr in Mar'25, whil..."
      },
      {
        "title": "Roopa Industries Hits New 52-Week Low at Rs. 45.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-hits-new-52-week-low-at-rs-4511-3697083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoopaIndustries_priceRelatedfactors_3697083.png",
        "date": "2025-11-13 10:02:34",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of Rs. 45.11 amid ongoing market challenges. The stock has underperformed its sector and shows a significant decline over the past year, reflecting weak financial metrics and a persistent downward trend."
      },
      {
        "title": "Roopa Industries Hits New 52-Week Low at Rs. 45.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-hits-new-52-week-low-at-rs-4511-3697082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoopaIndustries_priceRelatedfactors_3697082.png",
        "date": "2025-11-13 10:02:32",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of Rs. 45.11, following consecutive losses. The stock is trading below key moving averages and has seen a significant decline over the past year, indicating ongoing challenges for the company."
      },
      {
        "title": "Roopa Industries Hits New 52-Week Low at Rs. 45.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-hits-new-52-week-low-at-rs-4511-3697078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoopaIndustries_priceRelatedfactors_3697078.png",
        "date": "2025-11-13 10:01:13",
        "description": "Roopa Industries has hit a new 52-week low, reflecting a significant decline in its stock performance. The company has underperformed its sector and is trading below key moving averages. Despite a profit increase, its financial metrics indicate weak long-term strength, with a low ROCE and high Debt to EBITDA ratio."
      },
      {
        "title": "Is Roopa Industries overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-roopa-industries-overvalued-or-undervalued-3687647",
        "imagepath": "",
        "date": "2025-11-11 08:11:37",
        "description": "As of 10 November 2025, Roopa Industries has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued. Key ratios include a PE Ratio of 18.65, an EV to EBITDA of 14.98, and a PEG Ratio of 0.75, indicating strong potential for growth relative to its price.\n\nIn comparison to peers, Roopa Industries shows a more favorable valuation than Sun Pharma, which has a PE Ratio of 35.15 and is deemed expensive, as well as Divi's Lab, which is classified as very expensive with a PE Ratio of 71.55. Despite recent stock performance lagging behind the Sensex, particularly with a year-to-date return of -33.75% compared to the Sensex's 6.91%, the overall valuation metrics suggest that Roopa Industries presents a compelling investment opportunity...."
      },
      {
        "title": "Why is Roopa Industries falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-roopa-industries-fallingrising-3687019",
        "imagepath": "",
        "date": "2025-11-10 22:26:01",
        "description": "As of 10-Nov, Roopa Industries Ltd is experiencing a decline in its stock price, currently at Rs. 48.36, which represents a decrease of Rs. 1.67 or 3.34%. The stock has hit a new 52-week low of Rs. 46.51 today and has been underperforming its sector by 4.39%. Over the past two days, the stock has consecutively fallen, totaling a decline of 4.97%. Additionally, it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. The delivery volume has also significantly decreased, with a drop of 58.4% compared to the 5-day average, suggesting a lack of investor interest.\n\nIn the broader market context, Roopa Industries has underperformed relative to the Sensex, with a 1-week return of -5.36% compared to the benchmark's -0.53%. Over the past month, the stock has declined by 10.86%, while the Sensex has gained 1.25%. Year-to-date, Roopa Industries has seen a s..."
      }
    ],
    "total": 104,
    "sid": "796559",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/roopa-industries-796559"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "17-Jan-2026",
      "details": "Submission of Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31/12/2026",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window",
      "datetime": "16-Jan-2026",
      "details": "Report on re-lodgement of transfer requests of physical shares under Special Window for the period 1st December 2025 to 6th January 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Jan-2026",
      "details": "Publication of Notice to Shareholders",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Roopa Industries Stock Falls to 52-Week Low of Rs.42 Amid Volatility

2025-12-04 12:46:17

Roopa Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.42, reflecting a significant decline amid a day marked by high volatility and underperformance relative to its sector peers.

Roopa Industries Stock Falls to 52-Week Low of Rs.43 Amidst Volatile Trading

2025-11-25 10:46:24

Roopa Industries, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.43 today, marking a significant price level amid a day of high volatility and mixed intraday movements.

Roopa Industries Faces Financial Struggles Amid Declining Performance Metrics

2025-11-18 11:02:05

Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, reported a challenging financial quarter ending September 2025, with declines in key metrics such as operating cash flow and return on capital employed. Despite significant long-term growth, recent performance issues underscore the need for operational improvements.

How has been the historical performance of Roopa Industries?

2025-11-14 23:55:45

Answer: The historical performance of Roopa Industries shows significant growth in net sales and profit over the years. Breakdown: Roopa Industries has demonstrated a strong upward trend in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with a notable jump from 70.43 Cr in Mar'24. The total operating income followed a similar trajectory, reaching 120.69 Cr in Mar'25, up from 70.43 Cr in the previous year. However, raw material costs surged to 114.42 Cr in Mar'25, reflecting a substantial increase from 47.06 Cr in Mar'24. Despite this, the operating profit (PBDIT) rose to 6.41 Cr in Mar'25, compared to 5.68 Cr in Mar'24, indicating improved operational efficiency. Profit before tax also increased to 2.72 Cr in Mar'25 from 2.17 Cr in Mar'24, leading to a profit after tax of 2.03 Cr in Mar'25, up from 1.52 Cr in the prior year. The company's total assets grew to 76.46 Cr in Mar'25, whil...

Roopa Industries Hits New 52-Week Low at Rs. 45.11

2025-11-13 10:02:34

Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of Rs. 45.11 amid ongoing market challenges. The stock has underperformed its sector and shows a significant decline over the past year, reflecting weak financial metrics and a persistent downward trend.

Roopa Industries Hits New 52-Week Low at Rs. 45.11

2025-11-13 10:02:32

Roopa Industries, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of Rs. 45.11, following consecutive losses. The stock is trading below key moving averages and has seen a significant decline over the past year, indicating ongoing challenges for the company.

Roopa Industries Hits New 52-Week Low at Rs. 45.11

2025-11-13 10:01:13

Roopa Industries has hit a new 52-week low, reflecting a significant decline in its stock performance. The company has underperformed its sector and is trading below key moving averages. Despite a profit increase, its financial metrics indicate weak long-term strength, with a low ROCE and high Debt to EBITDA ratio.

Is Roopa Industries overvalued or undervalued?

2025-11-11 08:11:37

As of 10 November 2025, Roopa Industries has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued. Key ratios include a PE Ratio of 18.65, an EV to EBITDA of 14.98, and a PEG Ratio of 0.75, indicating strong potential for growth relative to its price. In comparison to peers, Roopa Industries shows a more favorable valuation than Sun Pharma, which has a PE Ratio of 35.15 and is deemed expensive, as well as Divi's Lab, which is classified as very expensive with a PE Ratio of 71.55. Despite recent stock performance lagging behind the Sensex, particularly with a year-to-date return of -33.75% compared to the Sensex's 6.91%, the overall valuation metrics suggest that Roopa Industries presents a compelling investment opportunity....

Why is Roopa Industries falling/rising?

2025-11-10 22:26:01

As of 10-Nov, Roopa Industries Ltd is experiencing a decline in its stock price, currently at Rs. 48.36, which represents a decrease of Rs. 1.67 or 3.34%. The stock has hit a new 52-week low of Rs. 46.51 today and has been underperforming its sector by 4.39%. Over the past two days, the stock has consecutively fallen, totaling a decline of 4.97%. Additionally, it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. The delivery volume has also significantly decreased, with a drop of 58.4% compared to the 5-day average, suggesting a lack of investor interest. In the broader market context, Roopa Industries has underperformed relative to the Sensex, with a 1-week return of -5.36% compared to the benchmark's -0.53%. Over the past month, the stock has declined by 10.86%, while the Sensex has gained 1.25%. Year-to-date, Roopa Industries has seen a s...

View All News